Results per Page:
Mapping the hidden diversity of pediatric brain tumors
From the Holland Lab, Human Biology Division
House of cards: therapeutic vulnerabilities in the tumor microenvironment
From the Gujral Lab, Human Biology Division
Showcasing new strides in rare cancer research
Fred Hutch 4th Rare Cancers Symposium features local and national experts in critical research areas including immunotherapy, clinical trial design and biobanking
Fred Hutch study finds new life for ‘ineffective’ drugs
Innovative method using more authentic tumor samples reveals untapped potential for drugs written off by more conventional tests
Kuni Foundation awards $7M to drive adult oncology research forward
Vancouver, Washington-based foundation supports innovative early-stage research on new potential therapies
Rare cancer researchers find promising target in fibrolamellar cancer
Fred Hutch’s TRACER initiative digs into aggressive liver cancer, hosts third rare cancer symposium
Cell death on a chip: new tools for a new era of cancer biology
From The Folch Lab, University of Washington Bioengineering Department and Cancer Basic Biology Program of the Cancer Consortium
Making the most of a small supply
Fred Hutch researchers receive $1.3 million grant from the U.S. Department of Defense to study the fundamental biology of five rare liver cancers that could lead to new treatments one day
$5.25M from the Kuni Foundation propels innovative adult oncology research
Grants will support research on tumor regression, immunotherapy access and better care for breast, liver and peritoneal malignancies
Charting new territory in detangling cytokine secretion mechanisms
From the Gujral Lab, Human Biology Division
Fred Hutch launches rare cancer research effort
New TRACER initiative aims to accelerate advances through multidisciplinary collaboration and innovative approaches
Six researchers receive $3.5 million in grants from Kuni Foundation
Funds will support innovative high-risk/high-reward projects across Fred Hutchinson Cancer Center/University of Washington/Seattle Children’s Cancer Consortium with the potential to revolutionize care
Fred Hutch/UW/Seattle Children’s Cancer Consortium breast cancer researchers receive grants
Breast Cancer Research Foundation supports projects including new imaging tracer, better risk prediction for luminal B subtypes, anti-inflammatory vaccine and more
Machine learning identifies biomarkers that predict a patient’s response to immunotherapy
From the Gujral Lab, Human Biology Division
Drug identified to combat Omicron-induced cytokine storm
From the Gujral Lab, Human Biology Division
Development of an in vitro model system to study tricky-to-target tumor microenvironment cells
From the Gujral Lab, Human Biology Division
Computational predictions reveal an unexpected synergy for prostate cancer therapy
From the Gujral Lab, Human Biology Division